CNBC Top Stories

Apple may see a drop in iPhone shipments this year, due in part to the growing popularity of foldable phones, analyst Ming-Chi Kuo says.

Sometimes, it's possible to pay rent with a credit card — but experts say it's risky.

The Deliveroo stake sale will fetch $97.4 million for Delivery Hero, less than a third of what it paid for the shares when it first bought them in 2021.

Most Americans pay for tax filing software even though many can do it for free using the IRS Free File program.

Building ample cash savings is all about developing a savings habit. Here's how experts coax clients to achieve that goal.

The International Monetary Fund sees a reduced likelihood of a so-called hard landing, with inflation falling faster than expected.

Booking.com released its list of the most welcoming cities on Earth for 2024 based on the brand's Traveler Review Awards.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

The attorney general's office said the alleged failure cost victims millions of dollars.

Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government. 

There is a need to put in place medium-term fiscal plans that will accommodate a significant increase in spending pressures, the IMF's chief economist said.

JetBlue said it expects 2024 capacity to be down in the low single digits and that its adjusted margins could approach breakeven.

Home prices in November fell 0.2% from October, according to the S&P CoreLogic Case-Shiller national home price index.

Super Micro shares pop on rosy second-quarter earnings beat and revenue forecast.

The industrial technology company will add two directors and expand its share buyback shortly after activist investor Jana Partners disclosed its stake.

Norway's sovereign wealth fund, the world's largest, was established in the 1990s to invest the surplus revenues of the country's oil and gas sector.

Quadir predicts that Adtalem is wasting federal tax dollars on programs that are ineffective, and that it faces several significant financial threats.

The in-human clinical trial marks just one step on Neuralink's path toward commercialization.

Activist investor Bluebell Capital Partners is pushing for BP to urgently change tack.

GM's 2023 earnings included several special charges, including $1.1 billion in North American strike costs and $792 million for new commercial agreements.